Literature DB >> 7736277

Immunohistochemical localization of cytochrome P450 3A in human pulmonary carcinomas and normal bronchial tissue.

K T Kivistö1, P Fritz, A Linder, G Friedel, P Beaune, H K Kroemer.   

Abstract

The cytochrome P450 (CYP) enzymes metabolize drugs and other xenobiotics in liver and also in some extrahepatic tissues. We have studied the expression and localization of CYP3A in primary lung tumours and normal lung tissue from the same patients. Thirty-two patients undergoing partial or total lung resection for therapy of primary pulmonary carcinoma were included in this study. Immunohistochemical staining for CYP3A was performed with a modification of the ABC technique. Eight of the 32 cases of primary pulmonary carcinoma showed expression of CYP3A. In 12 of the 32 cases of normal tissue, the seromucous glands were positive for CYP3A. The bronchial epithelium was positive for CYP3A in 11 cases. We observed no correlation between CYP3A expression in tumour tissue and that in seromucous glands or bronchial epithelium. We conclude that CYP3A is present in both normal and cancerous lung tissue. Our findings suggest, however, no co-expression of CYP3A in lung cancer.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7736277     DOI: 10.1007/bf01464472

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  17 in total

Review 1.  Diverse role of pulmonary cytochrome P-450 monooxygenase.

Authors:  Y Kikkawa
Journal:  Lab Invest       Date:  1992-11       Impact factor: 5.662

Review 2.  Ifosfamide/mesna. A review of its antineoplastic activity, pharmacokinetic properties and therapeutic efficacy in cancer.

Authors:  K L Dechant; R N Brogden; T Pilkington; D Faulds
Journal:  Drugs       Date:  1991-09       Impact factor: 9.546

3.  In situ localization and distribution of xenobiotic-activating enzymes and aryl hydrocarbon hydroxylase activity in lungs of untreated rats.

Authors:  J M Voigt; T T Kawabata; J P Burke; M V Martin; F P Guengerich; J Baron
Journal:  Mol Pharmacol       Date:  1990-02       Impact factor: 4.436

Review 4.  The pulmonary uptake, accumulation, and metabolism of xenobiotics.

Authors:  J R Bend; C J Serabjit-Singh; R M Philpot
Journal:  Annu Rev Pharmacol Toxicol       Date:  1985       Impact factor: 13.820

5.  The immunocytochemical localisation and distribution of cytochrome P-450 in normal human hepatic and extrahepatic tissues with a monoclonal antibody to human cytochrome P-450.

Authors:  G I Murray; T S Barnes; H F Sewell; S W Ewen; W T Melvin; M D Burke
Journal:  Br J Clin Pharmacol       Date:  1988-04       Impact factor: 4.335

Review 6.  The 1992 Bernard B. Brodie Award Lecture. Bioactivation and detoxication of toxic and carcinogenic chemicals.

Authors:  F P Guengerich
Journal:  Drug Metab Dispos       Date:  1993 Jan-Feb       Impact factor: 3.922

Review 7.  Pharmacogenetic phenotyping and genotyping. Present status and future potential.

Authors:  F J Gonzalez; J R Idle
Journal:  Clin Pharmacokinet       Date:  1994-01       Impact factor: 6.447

8.  Detection of human lung cytochromes P450 that are immunochemically related to cytochrome P450IIE1 and cytochrome P450IIIA.

Authors:  C W Wheeler; S A Wrighton; T M Guenthner
Journal:  Biochem Pharmacol       Date:  1992-07-07       Impact factor: 5.858

9.  Differential expression of drug metabolizing enzymes in primary and secondary liver neoplasm: immunohistochemical characterization of cytochrome P4503A and glutathione-S-transferase.

Authors:  P Fritz; E Behrle; P Beaune; M Eichelbaum; H K Kroemer
Journal:  Histochemistry       Date:  1993-06

Review 10.  Extrahepatic metabolism of drugs in humans.

Authors:  D R Krishna; U Klotz
Journal:  Clin Pharmacokinet       Date:  1994-02       Impact factor: 6.447

View more
  14 in total

Review 1.  Cytochrome P450 3A and their regulation.

Authors:  Oliver Burk; Leszek Wojnowski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-21       Impact factor: 3.000

Review 2.  Significance of the minor cytochrome P450 3A isoforms.

Authors:  Ann K Daly
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

Review 3.  Clinical pharmacokinetic considerations in the elderly. An update.

Authors:  M T Kinirons; P Crome
Journal:  Clin Pharmacokinet       Date:  1997-10       Impact factor: 6.447

Review 4.  Clinical pharmacokinetics and pharmacodynamics of ifosfamide and its metabolites.

Authors:  T Kerbusch; J de Kraker; H J Keizer; J W van Putten; H J Groen; R L Jansen; J H Schellens; J H Beijnen
Journal:  Clin Pharmacokinet       Date:  2001-01       Impact factor: 6.447

5.  Expression of cytochrome P 450 3A enzymes in human lung: a combined RT-PCR and immunohistochemical analysis of normal tissue and lung tumours.

Authors:  K T Kivistö; E U Griese; P Fritz; A Linder; J Hakkola; H Raunio; P Beaune; H K Kroemer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-01       Impact factor: 3.000

6.  The inhaled glucocorticoid fluticasone propionate efficiently inactivates cytochrome P450 3A5, a predominant lung P450 enzyme.

Authors:  Takahiro Murai; Christopher A Reilly; Robert M Ward; Garold S Yost
Journal:  Chem Res Toxicol       Date:  2010-08-16       Impact factor: 3.739

Review 7.  The role of human cytochrome P450 enzymes in the metabolism of anticancer agents: implications for drug interactions.

Authors:  K T Kivistö; H K Kroemer; M Eichelbaum
Journal:  Br J Clin Pharmacol       Date:  1995-12       Impact factor: 4.335

Review 8.  Update information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters.

Authors:  S Rendic; F P Guengerich
Journal:  Curr Drug Metab       Date:  2010-01       Impact factor: 3.731

9.  Potentiation of methoxymorpholinyl doxorubicin antitumor activity by P450 3A4 gene transfer.

Authors:  H Lu; C-S Chen; D J Waxman
Journal:  Cancer Gene Ther       Date:  2008-11-14       Impact factor: 5.987

10.  Immunohistochemical localization of cytochrome P450 2E1 in human pulmonary carcinoma and normal bronchial tissue.

Authors:  K T Kivistö; A Linder; G Friedel; P Beaune; C Belloc; H K Kroemer; P Fritz
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.